FDA clears Biotronik's pacemaker with home monitor:
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale Biotronik's Philos DR-T pacemaker with home monitoring technology, which is designed to automatically transmit critical data about the patient's current condition to the physician's office. The home monitor system will be incorporated in future product lines, including implantable cardioverter defibrillators, said the Lake Oswego, Oregon firm.